|
[1]
|
Babal, Y.K., Sonmez, E. and Aksan Kurnaz, I. (2023) Nervous System-Related Gene Regulatory Networks and Func-tional Evolution of ETS Proteins across Species. Bio Systems, 227-228, Article ID: 104891. [Google Scholar] [CrossRef] [PubMed]
|
|
[2]
|
Du, L., Liu, Y., Li, C., et al. (2022) The Interaction between ETS Transcription Factor Family Members and MicroRNAs: A Novel Approach to Cancer Therapy. Biomedicine & Pharmacotherapy, 150, Article ID: 113069. [Google Scholar] [CrossRef] [PubMed]
|
|
[3]
|
Kelle, D., Kırımtay, K., Selçuk, E., et al. (2019) Elk1 Affects Katanin and Spastin Proteins via Differential Transcriptional and Post-Transcriptional Regulations. PLOS ONE, 14, e0212518. [Google Scholar] [CrossRef] [PubMed]
|
|
[4]
|
Prise, I. and Sharrocks, A.D. (2019) ELK1 Has a Dual Activating and Repressive Role in Human Embryonic Stem Cells. Wellcome Open Research, 4, Article No. 41. [Google Scholar] [CrossRef]
|
|
[5]
|
Harel, S., Sanchez, V., Moamer, A., et al. (2021) ETS1, ELK1, and ETV4 Transcription Factors Regulate Angiopoietin-1 Signaling and the Angiogenic Response in Endothelial Cells. Frontiers in Physiology, 12, Article ID: 683651. [Google Scholar] [CrossRef] [PubMed]
|
|
[6]
|
Zhao, H., Chen, M., Wang, J., et al. (2020) PCNA-Associated Factor KIAA0101 Transcriptionally Induced by ELK1 Controls Cell Proliferation and Apoptosis in Nasopharyngeal Car-cinoma: An Integrated Bioinformatics and Experimental Study. Aging, 12, 5992-6017. [Google Scholar] [CrossRef] [PubMed]
|
|
[7]
|
Liu, J., Sun, Q., Zhao, J., et al. (2022) Early Death in Supraglottic Laryngeal Squamous Cell Carcinoma: A Population-Based Study. Ear, Nose & Throat Journal. [Google Scholar] [CrossRef] [PubMed]
|
|
[8]
|
Shuang, Y., Liu, J., Niu, J., et al. (2021) A Novel Circular RNA CircPPFIA1 Promotes Laryngeal Squamous Cell Carcinoma Progression through Sponging MiR-340-3p and Regulating ELK1 Expression. Bioengineered, 12, 5220-5230. [Google Scholar] [CrossRef] [PubMed]
|
|
[9]
|
Sung, H., Ferlay, J., Siegel, R.L., et al. (2021) Global Cancer Statistics 2020: GLOBOCAN Estimates of Incidence and Mortality Worldwide for 36 Cancers in 185 Countries. CA: A Cancer Journal for Clinicians, 71, 209-249. [Google Scholar] [CrossRef] [PubMed]
|
|
[10]
|
Li, K., Liu, Y., Ding, Y., et al. (2022) BCL6 Is Regulated by the MAPK/ELK1 Axis and Promotes KRAS-Driven Lung Cancer. The Journal of Clinical Investigation, 132, e161308. [Google Scholar] [CrossRef]
|
|
[11]
|
Yu, T.-T., Zhang, T., Su, F., et al. (2021) ELK1 Promotes Epitheli-al-Mesenchymal Transition and the Progression of Lung Adenocarcinoma by Upregulating B7-H3. Oxidative Medicine and Cellular Longevity, 2021, Article ID: 2805576. [Google Scholar] [CrossRef] [PubMed]
|
|
[12]
|
Xia, C., Dong, X., Li, H., et al. (2022) Cancer Statistics in China and United States, 2022: Profiles, Trends, and Determinants. Chinese Medical Journal, 135, 584-590. [Google Scholar] [CrossRef]
|
|
[13]
|
Morgan, E., Soerjomataram, I., Rumgay, H., et al. (2022) The Global Landscape of Esophageal Squamous Cell Carcinoma and Esophageal Adenocarcinoma Incidence and Mortal-ity in 2020 and Projections to 2040: New Estimates from GLOBOCAN 2020. Gastroenterology, 163, 649-658.E2. [Google Scholar] [CrossRef] [PubMed]
|
|
[14]
|
Zheng, Z.-Y., Chu, M.-Y., Lin, W., et al. (2022) Blocking STAT3 Signaling Augments MEK/ERK Inhibitor Efficacy in Esophageal Squamous Cell Carcinoma. Cell Death & Dis-ease, 13, Article No. 496. [Google Scholar] [CrossRef] [PubMed]
|
|
[15]
|
López, M.J., Carbajal, J., Alfaro, A.L., et al. (2023) Characteris-tics of Gastric Cancer around the World. Critical Reviews in Oncology/Hematology, 181, Article ID: 103841. [Google Scholar] [CrossRef] [PubMed]
|
|
[16]
|
Li, Z., Cheng, Y., Fu, K., et al. (2021) Circ-PTPDC1 Pro-motes the Progression of Gastric Cancer through Sponging Mir-139-3p by Regulating ELK1 and Functions as a Prog-nostic Biomarker. International Journal of Biological Sciences, 17, 4285-4304. [Google Scholar] [CrossRef] [PubMed]
|
|
[17]
|
Li, P., Ge, D., Li, P., et al. (2020) CXXC Finger Protein 4 Inhibits the CDK18‐ERK1/2 Axis to Suppress the Immune Escape of Gastric Cancer Cells with Involvement of ELK1/MIR100HG Pathway. Journal of Cellular and Molecular Medicine, 24, 10151-10165. [Google Scholar] [CrossRef] [PubMed]
|
|
[18]
|
Shinji, S., Yamada, T., Matsuda, A., et al. (2022) Recent Advances in the Treatment of Colorectal Cancer: A Review. Journal of Nippon Medical School, 89, 246-254. [Google Scholar] [CrossRef]
|
|
[19]
|
Zhao, S., Mi, Y., Zheng, B., et al. (2022) Highly‐Metastatic Colorectal Cancer Cell Released MiR‐181a‐5p‐Rich Extracellular Vesicles Promote Liver Metastasis by Activating He-patic Stellate Cells and Remodelling the Tumour Microenvironment. Journal of Extracellular Vesicles, 11, e12186. [Google Scholar] [CrossRef] [PubMed]
|
|
[20]
|
Yan, G. and Lei, W. (2023) Role of ELK1 in Regulating Colorectal Cancer Progression: MiR-31-5p/CDIP1 Axis in CRC Pathogenesis. PeerJ, 11, e15602. [Google Scholar] [CrossRef] [PubMed]
|
|
[21]
|
Ma, J., Liu, X., Chen, H., et al. (2021) C-KIT-ERK1/2 Signaling Activat-ed ELK1 and Upregulated Carcinoembryonic Antigen Expression to Promote Colorectal Cancer Progression. Cancer Science, 112, 655-667. [Google Scholar] [CrossRef] [PubMed]
|
|
[22]
|
Klein, A.P. (2021) Pancreatic Cancer Epidemiology: Understanding the Role of Lifestyle and Inherited Risk Factors. Nature Reviews. Gastroenterology & Hepatology, 18, 493-502. [Google Scholar] [CrossRef] [PubMed]
|
|
[23]
|
Yan, Q., Ni, C., Lin, Y., et al. (2021) ELK1 Enhances Pancreatic Cancer Progression via LGMN and Correlates with Poor Prognosis. Frontiers in Molecular Biosciences, 8, Article ID: 764900. [Google Scholar] [CrossRef] [PubMed]
|
|
[24]
|
Chen, Q., Fu, Y., Liu, X., et al. (2023) Aberrant Expres-sion of CKS2 Induced by ELK1 Contributes to Malignant Progression of Pancreatic Cancer. Molecular Carcinogenesis. [Google Scholar] [CrossRef] [PubMed]
|
|
[25]
|
Madani, S.P., Mirza‐Aghazadeh‐Attari, M., Mohseni, A., et al. (2023) Dif-fuse Infiltrative Hepatocellular Carcinoma: Multimodality Imaging Manifestations. Journal of Surgical Oncology, 127, 385-393. [Google Scholar] [CrossRef] [PubMed]
|
|
[26]
|
Yan, Q., Lou, G., Qian, Y., et al. (2016) SPAG9 Is Involved in Hepatocarcinoma Cell Migration and Invasion via Modulation of ELK1 Expression. OncoTargets and Therapy, 9, 1067-1075. [Google Scholar] [CrossRef]
|
|
[27]
|
Gilyazova, I., Enikeeva, K., Rafikova, G., et al. (2023) Epi-genetic and Immunological Features of Bladder Cancer. International Journal of Molecular Sciences, 24, Article No. 9854. [Google Scholar] [CrossRef] [PubMed]
|
|
[28]
|
Wang, J., Luo, J., Wu, X., et al. (2022) ELK1 Suppresses SYTL1 Expression by Recruiting HDAC2 in Bladder Cancer Progression. Human Cell, 35, 1961-1975. [Google Scholar] [CrossRef] [PubMed]
|
|
[29]
|
Wang, W., Chen, S., Song, X., et al. (2020) ELK1/LncRNA-SNHG7/MiR-2682-5p Feedback Loop Enhances Bladder Cancer Cell Growth. Life Sciences, 262, Arti-cle ID: 118386. [Google Scholar] [CrossRef] [PubMed]
|
|
[30]
|
Li, P., Shi, Y., Gao, D., et al. (2022) ELK1-Mediated YTHDF1 Drives Prostate Cancer Progression by Facilitating the Translation of Polo-Like Kinase 1 in an M6A Dependent Manner. International Journal of Biological Sciences, 18, 6145-6162. [Google Scholar] [CrossRef] [PubMed]
|
|
[31]
|
Xie, W., Li, S., Guo, H., et al. (2023) Androgen Receptor Knockdown En-hances Prostate Cancer Chemosensitivity by Down‐Regulating FEN1 through the ERK/ELK1 Signalling Pathway. Can-cer Medicine, 12, 15317-15336. [Google Scholar] [CrossRef] [PubMed]
|
|
[32]
|
Wei, S., Yu, Z., Shi, R., et al. (2022) GPX4 Suppresses Ferroptosis to Promote Malignant Progression of Endometrial Carcinoma via Transcriptional Activation by ELK1. BMC Cancer, 22, Article No. 881. [Google Scholar] [CrossRef] [PubMed]
|
|
[33]
|
Huang, Y. and Luo, F. (2021) Elevated MicroRNA-130b-5p or Silenced ELK1 Inhibits Self-Renewal Ability, Proliferation, Migration, and Invasion Abilities, and Promotes Apoptosis of Cervical Cancer Stem Cells. IUBMB Life, 73, 118-129. [Google Scholar] [CrossRef] [PubMed]
|
|
[34]
|
Hu, R. and Zhu, Z. (2019) ELK1‐Activated GPC3‐AS1/GPC3 Axis Promotes the Proliferation and Migration of Cervical Cancer Cells. The Journal of Gene Medicine, 21, e3099. [Google Scholar] [CrossRef] [PubMed]
|
|
[35]
|
Trapani, D., Ginsburg, O., Fadelu, T., et al. (2022) Global Challenges and Policy Solutions in Breast Cancer Control. Cancer Treatment Reviews, 104, Article ID: 102339. [Google Scholar] [CrossRef] [PubMed]
|
|
[36]
|
Yang, B., Wang, H., Xiao, J., et al. (2023) ELK1 / KIFC1 Axis Promotes Breast Cancer Cell Proliferation by Regulating Glutathione Metabolism. Journal of Obstetrics and Gynaecology Research, 49, 2175-2184. [Google Scholar] [CrossRef] [PubMed]
|
|
[37]
|
Wang, S., Zhang, H., Liu, H., et al. (2021) ELK1-Induced Up-Regulation of KIF26B Promotes Cell Cycle Progression in Breast Cancer. Medical Oncology (Northwood, London, England), 39, Ar-ticle No. 15. [Google Scholar] [CrossRef] [PubMed]
|
|
[38]
|
Zhang, Q., Wu, J., Zhang, X., et al. (2021) Transcription Factor ELK1 Accelerates Aerobic Glycolysis to Enhance Osteosarcoma Chemoresistance through MiR-134/PTBP1 Signaling Cascade. Aging, 13, 6804-6819. [Google Scholar] [CrossRef] [PubMed]
|
|
[39]
|
Guo, D., Zhang, A., Suo, M., et al. (2023) ELK1-Induced Upregula-tion of Long Non-Coding TNK2-AS1 Promotes the Progression of Acute Myeloid Leukemia by EZH2-Mediated Epige-netic Silencing of CELF2. Cell Cycle (Georgetown, Tex.), 22, 117-130. [Google Scholar] [CrossRef] [PubMed]
|
|
[40]
|
Chava, S., Bugide, S., Malvi, P., et al. (2022) Co-Targeting of Specific Epigenetic Regulators in Combination with CDC7 Potently Inhibit Melanoma Growth. IScience, 25, Article ID: 104752. [Google Scholar] [CrossRef] [PubMed]
|
|
[41]
|
Sogut, M.S., Venugopal, C., Kandemir, B., et al. (2021) ETS-Domain Transcription Factor Elk-1 Regulates Stemness Genes in Brain Tumors and CD133+ Brain Tu-mor-Initiating Cells. Journal of Personalized Medicine, 11, Article No. 125. [Google Scholar] [CrossRef] [PubMed]
|
|
[42]
|
Lv, P. and Xue, Y. (2021) ETS Like-1 Protein ELK1-Induced LncRNA LINC01638 Accelerates the Progression of Papillary Thyroid Cancer by Regulating Axin2 through Wnt/β-Catenin Sig-naling Pathway. Bioengineered, 12, 3873- 3885. [Google Scholar] [CrossRef] [PubMed]
|